Features | Partner Sites | Information | LinkXpress
Sign In
PURITAN MEDICAL
GLOBETECH PUBLISHING LLC
GLOBETECH PUBLISHING LLC

New Workstation Provides Superior Pipetting Performance with Advanced Technologies

By BiotechDaily International staff writers
Posted on 01 Oct 2013
Image: The new VANTAGE liquid handling workstation from Hamilton Robotics (Photo courtesy of Hamilton Robotics).
Image: The new VANTAGE liquid handling workstation from Hamilton Robotics (Photo courtesy of Hamilton Robotics).
A new liquid handling platform provides superior performance for simple to complex pipetting needs, plus an integration option to simplify laboratory automation.

Hamilton Robotics (Reno, NV, USA) now offers the “Vantage” workstation, a highly flexible, multipurpose pipetting platform featuring a completely new, state-of-the-art linear motor design and contact-free NanoPulse pipetting technology covering a wide volume range (100 nL–1 mL). This affordable liquid handler is space-efficient and enables users to prepare samples with the utmost precision and traceability, helping to ensure downstream data reliability.


"The Hamilton VANTAGE caters to all market needs, from a low-cost pipettor to the most complex integrated system, and is field upgradable to cover the entire usability pyramid," said Jose Carle, vice president of Hamilton Robotics. Its expandable design also makes it a valuable instrument for labs with growing needs or new applications. Labs requiring increased walk-away time, high throughputs, or large capacities can upgrade their bench-top VANTAGE pipettor at any time with a Logistics Cabinet, which offers innovative tip and plate shuttling from below the pipetting deck and customizable, smart waste solutions.


A telescopic, vertical Track Gripper can also be added to transport samples from below- or off-deck third-party devices such as thermal cyclers, centrifuges, washers, readers, sealers, peelers, and incubators. "A single vertically integrated system can easily replace four to six other pipetting robots and offers much more functionality than competitor's platforms," said Alvaro Cuevas, VANTAGE Senior Product Manager. “Overall, this saves customers money and enables them to build process redundancy with a second robot at the same price point."


In addition to the hardware, INSTINCT V software brings ease of use to the next level with automation intelligence, making VANTAGE accessible to varying user levels. The graphical Assay Editor allows a user to program in a "lab person's language" while the XSL Editor can be used for more complex programming tasks. INSTINCT V's resource-optimized, dynamic Scheduler allows users to run the same or different assays in parallel on an instrument while other users connect remotely to write methods for new assays. INSTINCT V also provides remote system monitoring via smart phones, tablets, or any web-enabled device, which increases walk-away time for overnight and weekend runs.

Related Links:
Hamilton Robotics
VANTAGE Workstation




Channels

Genomics/Proteomics

view channel
Image: The photomicrograph shows the head of a mouse embryo in which the pericytes are visible as blue dots along the blood vessel (Photo courtesy of the University of Gothenburg).

Genetically Engineered Mouse Model Reveals Key to Formation of the Blood-Brain Barrier

Use of a mouse model that had been genetically engineered to lack the gene that encodes the forkhead transcription factor Foxf2 has helped to explain how pericytes, cells that line the capillaries, form... Read more

Drug Discovery

view channel
Image: Scanning electron microscope (SEM) image of a field of polypyrrole nanowires (Photo courtesy of Dr. Richard Borgens, Purdue University).

Novel Controlled-Release Drug Delivery System Heals Spinal Inflammation in Mouse Model

A novel drug delivery system that allows controllable release of an anti-inflammatory agent directly to the site of inflammation or injury was tested successfully in a mouse model. Investigators at... Read more

Business

view channel

Biopharm Startup to Commercialize Antibody Therapy for Drug Resistant Cancers

A biopharm startup company has licensed the rights to commercialize an antibody-based approach for treatment of drug resistant cancers. The new company, CadheRx Therapeutics (La Jolla, CA, USA), entered into a licensing agreement with Stony Brook University (NY, USA) to develop and market an anticancer technology derived... Read more
 
Copyright © 2000-2015 Globetech Media. All rights reserved.